Remove 2021 Remove Debt Financing Remove Market Capitalization
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in.

article thumbnail

The Corporate Tax Burden: Facts and Fiction

Musings on Markets

For instance, the 2017 US tax reform act, in addition to lowering the corporate tax rate, also changed the way that foreign income to US companies was taxed and put limits on the tax deductibility of debt. It thus weights bigger companies more than smaller companies. billion in accrual taxes and $15.98 billion in cash taxes.